Share on StockTwits

Biomerica (NASDAQ:BMRA) announced its earnings results on Wednesday. The company reported $0.02 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.02, American Banking News reports.

Biomerica (NASDAQ:BMRA) opened at 0.86 on Wednesday. Biomerica has a 52-week low of $0.69 and a 52-week high of $1.10. The stock has a 50-day moving average of $0.88 and a 200-day moving average of $0.85. The company’s market cap is $6.5 million.

Biomerica, Inc(NASDAQ:BMRA), develops, manufactures, and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions.

Receive News & Ratings for Biomerica Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.